INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Grant or awardVerified data

Quake Stephen reported ABCL

Director · AbCellera Biologics Inc. · AbCellera Biologics Inc. — Share option (right to buy)

Side
A
Value
—
Shares
194.9K
Price
—
Executed
Dec 1, 2025
Disclosed
Dec 19, 2025
Disclosure timeline18 days from execution to publication · legal deadline 2 business days
Dec 1 executedDec 19, 2025 disclosed

ABCL · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
19/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing+10 / 15

    Disclosed 14 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ABCL

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    39
    BA
    Booth AndrewChief Financial Officer
    ABCLAbCellera Biologics Inc.
    Open-market purchase
    		BUY$384K
    37.2K sh
    		Aug 14, 2026Aug 14, 2026
    traded Aug 14, 2026
    		+0dSEC FORM 4

    Evidence

    12
    TH
    Thermopylae Holdings Ltd.10% Owner
    ABCLAbCellera Biologics Inc.
    Gift
    		G—
    225.0K sh
    		Dec 18, 2025Dec 19, 2025
    traded Dec 18, 2025
    		+1dSEC FORM 4

    Evidence

    40
    MS
    Montalbano John S.Director
    ABCLAbCellera Biologics Inc.
    Open-market purchase
    		BUY$178K
    50.0K sh
    		Nov 26, 2025Nov 26, 2025
    traded Nov 26, 2025
    		+0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001685889-25-000008
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Dec 1, 2025
    Published
    Dec 19, 2025
    Ingested by INSIDER
    Nov 5, 04:26 UTC
    Last re-read
    Nov 5, 04:26 UTC

    Extracted facts

    Filer
    Quake Stephen
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    AbCellera Biologics Inc. — Share option (right to buy)
    Ticker
    ABCL
    Shares
    194.9K
    Price per share
    $0
    Execution date (reported)
    Dec 1, 2025
    Owned after transaction
    194.9K shares
    Days from execution to publication
    18

    What this establishes

    Quake Stephen filed this Form 4 reporting a grant or award of ABCL on Dec 1, 2025. It became public on Dec 19, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Quake Stephencik:0001685889
    Issuer
    AbCellera Biologics Inc.cik:0001703057

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.